Stockscreener 앱 받기
3.55
1.93%
-0.07
시간 외 거래:
3.55
전일 마감가:
$3.62
열려 있는:
$3.63
하루 거래량:
273.21K
Relative Volume:
0.66
시가총액:
$108.92M
수익:
$875.70K
순이익/손실:
$-39.57M
주가수익비율:
-2.6447
EPS:
-1.3423
순현금흐름:
$-33.65M
1주 성능:
+6.29%
1개월 성능:
+21.58%
6개월 성능:
+31.48%
1년 성능:
+8.90%
1일 변동 폭
$3.52
$3.6965
1주일 범위
$3.34
$3.88
52주 변동 폭
$1.90
$3.88
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
명칭
Vistagen Therapeutics Inc
전화
650-577-3600
주소
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
VTGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTGN
Vistagen Therapeutics Inc
|
3.55 | 111.06M | 875.70K | -39.57M | -33.65M | -1.3423 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-08-07 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-07-22 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-22 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-07-22 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-05-20 | 개시 | Robert W. Baird | Outperform |
| 2021-02-18 | 개시 | Jefferies | Buy |
| 2021-01-04 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2018-06-27 | 개시 | Maxim Group | Buy |
| 2018-02-08 | 재확인 | Chardan Capital Markets | Buy |
| 2017-03-28 | 개시 | Maxim Group | Buy |
모두보기
Vistagen Therapeutics Inc 주식(VTGN)의 최신 뉴스
Can Vistagen Therapeutics Inc. rally from current levelsWeekly Profit Report & Proven Capital Preservation Methods - Newser
Using AI based signals to follow Vistagen Therapeutics Inc.2025 Fundamental Recap & Weekly High Momentum Picks - Newser
Price momentum metrics for Vistagen Therapeutics Inc. explainedPortfolio Growth Summary & Weekly Chart Analysis and Trade Guides - Newser
Real time social sentiment graph for Vistagen Therapeutics Inc.July 2025 News Drivers & Technical Analysis for Trade Confirmation - Newser
Is Vistagen Therapeutics Inc. stock undervalued right nowJuly 2025 Short Interest & Growth Oriented Trading Recommendations - خودرو بانک
Is this a good reentry point in Vistagen Therapeutics Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser
How to build a custom watchlist for Vistagen Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser
ADAR1 Capital Management LLC Buys 299,304 Shares of VistaGen Therapeutics, Inc. $VTGN - MarketBeat
Vistagen Therapeutics Inc. stock retracement – recovery analysis2025 Key Highlights & Weekly High Return Stock Opportunities - Newser
Earnings visualization tools for Vistagen Therapeutics Inc.Stop Loss & Fast Gain Stock Trading Tips - Newser
How to monitor Vistagen Therapeutics Inc. with trend dashboardsMarket Growth Review & Growth-Oriented Investment Plans - Newser
Can trapped investors hope for a rebound in Vistagen Therapeutics Inc.July 2025 Movers & Expert Approved Momentum Ideas - Newser
Technical analysis overview for Vistagen Therapeutics Inc. stockEarnings Risk Report & AI Enhanced Trading Alerts - Newser
Vistagen Therapeutics Inc. stock outlook for YEARJuly 2025 PreEarnings & Growth-Oriented Investment Plans - Newser
Measuring Vistagen Therapeutics Inc.’s beta against major indicesWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - Newser
Is Vistagen Therapeutics Inc. forming a bullish divergenceJobs Report & Capital Efficient Trade Techniques - khodrobank.com
Tick level data insight on Vistagen Therapeutics Inc. volatilityCEO Change & Free High Return Stock Watch Alerts - Newser
Vistagen Therapeutics Inc. stock chart pattern explainedIPO Watch & Weekly High Return Stock Opportunities - Newser
Is Vistagen Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Action & High Accuracy Swing Entry Alerts - Newser
Why is Vistagen Therapeutics Inc. stock going down2025 Growth vs Value & Accurate Buy Signal Notifications - خودرو بانک
What to do if you’re stuck in Vistagen Therapeutics Inc.Earnings Growth Summary & Weekly Market Pulse Updates - Newser
Should you buy the dip on Vistagen Therapeutics Inc.2025 Analyst Calls & Fast Gaining Stock Strategy Reports - خودرو بانک
Is Vistagen Therapeutics Inc.’s growth already priced inJuly 2025 Patterns & Low Risk High Win Rate Stock Picks - خودرو بانک
Using flow based indicators on Vistagen Therapeutics Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
VistaGen Bets On Nasal Therapies For Anxiety And Depression - Finimize
Is Vistagen Therapeutics Inc. a top pick in the sectorJuly 2025 Drop Watch & Smart Investment Allocation Insights - خودرو بانک
Published on: 2025-09-02 16:30:46 - خودرو بانک
Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial - Yahoo Finance
Is this a good reentry point in Vistagen Therapeutics Inc2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Published on: 2025-08-31 23:17:23 - Newser
Short interest data insights for Vistagen Therapeutics Inc.2025 Winners & Losers & AI Driven Stock Reports - Newser
What candlestick patterns are forming on Vistagen Therapeutics Inc.July 2025 Sentiment & Free Reliable Trade Execution Plans - Newser
Will Vistagen Therapeutics Inc. Benefit From Sector Tailwinds getLinesFromResByArray error: size == 0 - 더경남뉴스
Published on: 2025-08-30 22:37:47 - Newser
Vistagen Therapeutics Inc (VTGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):